Slovenia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.84 (0.73 - 0.95) 2019 Modelled IHME
0.89 (0.79 - 1) 2018 Modelled IHME
0.91 (0.79 - 1.03) 2017 Modelled IHME
0.9 (0.79 - 1.02) 2016 Modelled IHME
0.9 (0.77 - 1.02) 2015 Modelled IHME
0.9 (0.78 - 1.02) 2014 Modelled IHME
0.92 (0.80 - 1.04) 2013 Modelled IHME
0.93 (0.82 - 1.06) 2012 Modelled IHME
0.95 (0.84 - 1.08) 2011 Modelled IHME
0.97 (0.84 - 1.11) 2010 Modelled IHME
0.98 (0.85 - 1.12) 2009 Modelled IHME
0.99 (0.87 - 1.12) 2008 Modelled IHME
1 (0.87 - 1.13) 2007 Modelled IHME
1.01 (0.87 - 1.15) 2006 Modelled IHME
1.03 (0.87 - 1.17) 2005 Modelled IHME
1.04 (0.89 - 1.18) 2004 Modelled IHME
1.05 (0.91 - 1.19) 2003 Modelled IHME
1.07 (0.92 - 1.21) 2002 Modelled IHME
1.08 (0.93 - 1.23) 2001 Modelled IHME
1.09 (0.93 - 1.25) 2000 Modelled IHME
1.1 (0.94 - 1.26) 1999 Modelled IHME
1.12 (0.95 - 1.28) 1998 Modelled IHME
1.13 (0.96 - 1.29) 1997 Modelled IHME
1.14 (0.96 - 1.30) 1996 Modelled IHME
1.14 (0.96 - 1.31) 1995 Modelled IHME
1.14 (0.97 - 1.31) 1994 Modelled IHME
1.14 (0.97 - 1.30) 1993 Modelled IHME
1.14 (0.97 - 1.30) 1992 Modelled IHME
1.13 (0.96 - 1.29) 1991 Modelled IHME
1.13 (0.95 - 1.29) 1990 Modelled IHME
1.07 (0.15 - 8.32) 2015 Modelled WHO
1 (0.40 - 1.10) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2019 Modelled IHME
0.07 (0.05 - 0.09) 2018 Modelled IHME
0.07 (0.05 - 0.09) 2017 Modelled IHME
0.07 (0.05 - 0.09) 2016 Modelled IHME
0.07 (0.05 - 0.09) 2015 Modelled IHME
0.06 (0.05 - 0.08) 2014 Modelled IHME
0.06 (0.04 - 0.08) 2013 Modelled IHME
0.05 (0.04 - 0.06) 2012 Modelled IHME
0.04 (0.03 - 0.06) 2011 Modelled IHME
0.04 (0.03 - 0.05) 2010 Modelled IHME
0.04 (0.03 - 0.05) 2009 Modelled IHME
0.04 (0.03 - 0.05) 2008 Modelled IHME
0.04 (0.02 - 0.05) 2007 Modelled IHME
0.04 (0.02 - 0.05) 2006 Modelled IHME
0.03 (0.02 - 0.05) 2005 Modelled IHME
0.04 (0.02 - 0.05) 2004 Modelled IHME
0.04 (0.03 - 0.05) 2003 Modelled IHME
0.04 (0.03 - 0.05) 2002 Modelled IHME
0.04 (0.03 - 0.06) 2001 Modelled IHME
0.05 (0.04 - 0.07) 2000 Modelled IHME
0.1 (0.07 - 0.14) 1999 Modelled IHME
0.22 (0.15 - 0.30) 1998 Modelled IHME
0.36 (0.25 - 0.48) 1997 Modelled IHME
0.47 (0.33 - 0.64) 1996 Modelled IHME
0.52 (0.36 - 0.71) 1995 Modelled IHME
0.52 (0.37 - 0.71) 1994 Modelled IHME
0.52 (0.36 - 0.70) 1993 Modelled IHME
0.52 (0.36 - 0.69) 1992 Modelled IHME
0.51 (0.35 - 0.67) 1991 Modelled IHME
0.5 (0.34 - 0.65) 1990 Modelled IHME
1.04 (0.14 - 8.39) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
22,244 (18,756 - 25,501) 1990 Modelled IHME
22,400 (19,021 - 25,542) 1991 Modelled IHME
22,506 (19,159 - 25,679) 1992 Modelled IHME
22,574 (19,183 - 25,766) 1993 Modelled IHME
22,614 (19,243 - 25,920) 1994 Modelled IHME
22,638 (19,128 - 26,039) 1995 Modelled IHME
22,589 (19,112 - 25,898) 1996 Modelled IHME
22,429 (19,054 - 25,700) 1997 Modelled IHME
22,202 (18,905 - 25,434) 1998 Modelled IHME
21,953 (18,734 - 25,099) 1999 Modelled IHME
21,728 (18,587 - 24,905) 2000 Modelled IHME
21,513 (18,557 - 24,458) 2001 Modelled IHME
21,278 (18,454 - 24,059) 2002 Modelled IHME
21,037 (18,198 - 23,843) 2003 Modelled IHME
20,804 (17,831 - 23,613) 2004 Modelled IHME
20,596 (17,521 - 23,455) 2005 Modelled IHME
20,414 (17,598 - 23,133) 2006 Modelled IHME
20,244 (17,604 - 22,843) 2007 Modelled IHME
20,081 (17,523 - 22,651) 2008 Modelled IHME
19,916 (17,348 - 22,670) 2009 Modelled IHME
19,738 (17,173 - 22,622) 2010 Modelled IHME
19,488 (17,106 - 22,187) 2011 Modelled IHME
19,164 (16,812 - 21,811) 2012 Modelled IHME
18,842 (16,430 - 21,398) 2013 Modelled IHME
18,608 (16,030 - 21,146) 2014 Modelled IHME
18,535 (15,825 - 21,160) 2015 Modelled IHME
18,703 (16,304 - 21,075) 2016 Modelled IHME
18,863 (16,471 - 21,331) 2017 Modelled IHME
18,456 (16,299 - 20,667) 2018 Modelled IHME
17,487 (15,224 - 19,712) 2019 Modelled IHME
21,000 (9,000 - 23,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.08 (4.94 - 10.10) 2019 Modelled IHME
7.01 (4.98 - 9.82) 2018 Modelled IHME
6.92 (5.15 - 9.13) 2017 Modelled IHME
6.82 (5.16 - 8.81) 2016 Modelled IHME
6.87 (5.31 - 8.79) 2015 Modelled IHME
6.66 (5.08 - 8.46) 2014 Modelled IHME
7.27 (5.59 - 9.31) 2013 Modelled IHME
7.54 (5.76 - 9.71) 2012 Modelled IHME
7.49 (5.71 - 9.62) 2011 Modelled IHME
7.82 (5.97 - 9.99) 2010 Modelled IHME
8.43 (6.42 - 10.80) 2009 Modelled IHME
9.8 (7.55 - 12.40) 2008 Modelled IHME
11.3 (8.77 - 14.20) 2007 Modelled IHME
12.3 (9.63 - 15.40) 2006 Modelled IHME
12.4 (9.73 - 15.48) 2005 Modelled IHME
13.3 (10.40 - 16.50) 2004 Modelled IHME
13.9 (10.90 - 17.40) 2003 Modelled IHME
13.5 (10.60 - 17) 2002 Modelled IHME
13.9 (10.80 - 17.30) 2001 Modelled IHME
13.36 (10.50 - 16.60) 2000 Modelled IHME
13.3 (10.40 - 16.50) 1999 Modelled IHME
13 (10.10 - 16.10) 1998 Modelled IHME
12.7 (9.91 - 15.60) 1997 Modelled IHME
12.5 (9.35 - 16.20) 1996 Modelled IHME
12.4 (8.96 - 16.70) 1995 Modelled IHME
12.4 (8.79 - 16.90) 1994 Modelled IHME
12.4 (8.61 - 17.40) 1993 Modelled IHME
12.4 (8.65 - 17.20) 1992 Modelled IHME
12.5 (8.68 - 17.30) 1991 Modelled IHME
12.6 (8.65 - 17.40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
147 (103 - 209) 2019 Modelled IHME
145 (103 - 204) 2018 Modelled IHME
144 (107 - 189) 2017 Modelled IHME
141 (107 - 183) 2016 Modelled IHME
142 (110 - 182) 2015 Modelled IHME
137 (105 - 175) 2014 Modelled IHME
150 (115 - 192) 2013 Modelled IHME
155 (118 - 199) 2012 Modelled IHME
153 (117 - 197) 2011 Modelled IHME
160 (122 - 204) 2010 Modelled IHME
171 (131 - 219) 2009 Modelled IHME
199 (153 - 251) 2008 Modelled IHME
228 (177 - 286) 2007 Modelled IHME
248 (194 - 310) 2006 Modelled IHME
250 (195 - 311) 2005 Modelled IHME
266 (209 - 329) 2004 Modelled IHME
278 (218 - 347) 2003 Modelled IHME
270 (212 - 339) 2002 Modelled IHME
278 (216 - 345) 2001 Modelled IHME
266 (209 - 331) 2000 Modelled IHME
264 (207 - 328) 1999 Modelled IHME
259 (201 - 321) 1998 Modelled IHME
253 (197 - 311) 1997 Modelled IHME
248 (186 - 323) 1996 Modelled IHME
247 (178 - 331) 1995 Modelled IHME
247 (175 - 336) 1994 Modelled IHME
247 (171 - 345) 1993 Modelled IHME
244 (171 - 340) 1992 Modelled IHME
248 (172 - 343) 1991 Modelled IHME
249 (170 - 344) 1990 Modelled IHME
165 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
20 (14 - 28) 2019 Modelled IHME
21 (14 - 29) 2018 Modelled IHME
21 (15 - 29) 2017 Modelled IHME
21 (15 - 29) 2016 Modelled IHME
21 (14 - 29) 2015 Modelled IHME
21 (14 - 29) 2014 Modelled IHME
21 (15 - 29) 2013 Modelled IHME
21 (15 - 29) 2012 Modelled IHME
21 (15 - 30) 2011 Modelled IHME
21 (15 - 30) 2010 Modelled IHME
22 (15 - 30) 2009 Modelled IHME
23 (16 - 31) 2008 Modelled IHME
23 (17 - 32) 2007 Modelled IHME
24 (17 - 33) 2006 Modelled IHME
25 (17 - 34) 2005 Modelled IHME
25 (18 - 34) 2004 Modelled IHME
25 (18 - 34) 2003 Modelled IHME
25 (17 - 34) 2002 Modelled IHME
25 (17 - 34) 2001 Modelled IHME
25 (18 - 34) 2000 Modelled IHME
25 (18 - 34) 1999 Modelled IHME
25 (18 - 34) 1998 Modelled IHME
24 (18 - 33) 1997 Modelled IHME
24 (17 - 33) 1996 Modelled IHME
24 (17 - 33) 1995 Modelled IHME
24 (17 - 33) 1994 Modelled IHME
24 (17 - 33) 1993 Modelled IHME
24 (17 - 33) 1992 Modelled IHME
24 (17 - 33) 1991 Modelled IHME
24 (17 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
85 (65 - 122) 2014 Survey/reported Slovenia National Institute of Public Health, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
62 2016 Survey/reported EMCDDA, 2019
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.22 (0.99 - 1.51) 2019 Modelled IHME
1.21 (0.98 - 1.48) 2018 Modelled IHME
1.2 (0.98 - 1.46) 2017 Modelled IHME
1.2 (0.98 - 1.46) 2016 Modelled IHME
1.2 (0.97 - 1.47) 2015 Modelled IHME
1.21 (0.98 - 1.47) 2014 Modelled IHME
1.21 (0.99 - 1.47) 2013 Modelled IHME
1.22 (0.99 - 1.48) 2012 Modelled IHME
1.22 (1 - 1.48) 2011 Modelled IHME
1.23 (1 - 1.49) 2010 Modelled IHME
1.23 (1 - 1.49) 2009 Modelled IHME
1.23 (1.01 - 1.51) 2008 Modelled IHME
1.24 (1.01 - 1.53) 2007 Modelled IHME
1.24 (1.01 - 1.54) 2006 Modelled IHME
1.25 (1.01 - 1.55) 2005 Modelled IHME
1.25 (1.02 - 1.55) 2004 Modelled IHME
1.26 (1.03 - 1.55) 2003 Modelled IHME
1.26 (1.03 - 1.55) 2002 Modelled IHME
1.27 (1.04 - 1.55) 2001 Modelled IHME
1.27 (1.03 - 1.55) 2000 Modelled IHME
1.27 (1.03 - 1.55) 1999 Modelled IHME
1.27 (1.03 - 1.54) 1998 Modelled IHME
1.27 (1.03 - 1.55) 1997 Modelled IHME
1.27 (1.03 - 1.55) 1996 Modelled IHME
1.27 (1.03 - 1.55) 1995 Modelled IHME
1.27 (1.03 - 1.55) 1994 Modelled IHME
1.27 (1.03 - 1.56) 1993 Modelled IHME
1.26 (1.02 - 1.56) 1992 Modelled IHME
1.26 (1.02 - 1.55) 1991 Modelled IHME
1.25 (1.01 - 1.54) 1990 Modelled IHME
0.3 (0.20 - 0.30) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
30.5 (26.40 - 34.50) 2014 Modelled Degenhardt L et al, 2017
32.1 (23.60 - 41.60) 2009 Survey/reported EMCDDA
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.1 (0.10 - 0.20) 2013 Survey/reported Kopilovic B PM et al, 2015
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
24,701 (20,000 - 30,369) 1990 Modelled IHME
24,855 (20,057 - 30,556) 1991 Modelled IHME
24,989 (20,244 - 30,794) 1992 Modelled IHME
25,100 (20,410 - 30,840) 1993 Modelled IHME
25,184 (20,434 - 30,730) 1994 Modelled IHME
25,237 (20,402 - 30,852) 1995 Modelled IHME
25,269 (20,442 - 30,775) 1996 Modelled IHME
25,292 (20,528 - 30,782) 1997 Modelled IHME
25,306 (20,578 - 30,732) 1998 Modelled IHME
25,317 (20,592 - 30,771) 1999 Modelled IHME
25,328 (20,613 - 30,807) 2000 Modelled IHME
25,307 (20,644 - 30,976) 2001 Modelled IHME
25,239 (20,644 - 30,965) 2002 Modelled IHME
25,151 (20,548 - 31,064) 2003 Modelled IHME
25,068 (20,416 - 30,983) 2004 Modelled IHME
25,020 (20,316 - 31,049) 2005 Modelled IHME
25,005 (20,401 - 30,896) 2006 Modelled IHME
25,001 (20,369 - 30,810) 2007 Modelled IHME
25,007 (20,369 - 30,562) 2008 Modelled IHME
25,021 (20,340 - 30,375) 2009 Modelled IHME
25,033 (20,360 - 30,311) 2010 Modelled IHME
25,024 (20,439 - 30,246) 2011 Modelled IHME
24,989 (20,391 - 30,352) 2012 Modelled IHME
24,942 (20,350 - 30,318) 2013 Modelled IHME
24,908 (20,228 - 30,264) 2014 Modelled IHME
24,897 (20,126 - 30,405) 2015 Modelled IHME
24,893 (20,323 - 30,211) 2016 Modelled IHME
24,903 (20,314 - 30,284) 2017 Modelled IHME
25,036 (20,367 - 30,606) 2018 Modelled IHME
25,305 (20,634 - 31,275) 2019 Modelled IHME
6,000 (4,000 - 7,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.17 (5.74 - 11.30) 2019 Modelled IHME
8.1 (5.87 - 11) 2018 Modelled IHME
8 (6.01 - 10.50) 2017 Modelled IHME
7.87 (6.14 - 9.98) 2016 Modelled IHME
7.92 (6.21 - 10) 2015 Modelled IHME
7.68 (5.97 - 9.80) 2014 Modelled IHME
8.25 (6.46 - 10.60) 2013 Modelled IHME
8.47 (6.65 - 10.80) 2012 Modelled IHME
8.35 (6.48 - 10.60) 2011 Modelled IHME
8.58 (6.64 - 11) 2010 Modelled IHME
8.51 (6.56 - 11) 2009 Modelled IHME
8.43 (6.51 - 11) 2008 Modelled IHME
8.28 (6.38 - 10.80) 2007 Modelled IHME
7.94 (6.13 - 10.30) 2006 Modelled IHME
7.64 (5.92 - 10) 2005 Modelled IHME
8.09 (6.12 - 10.70) 2004 Modelled IHME
8.38 (6.36 - 11.10) 2003 Modelled IHME
8.23 (6.19 - 10.90) 2002 Modelled IHME
8.47 (6.49 - 11.30) 2001 Modelled IHME
8.14 (6.14 - 10.80) 2000 Modelled IHME
8.08 (6.11 - 10.70) 1999 Modelled IHME
7.9 (5.96 - 10.50) 1998 Modelled IHME
7.71 (5.83 - 10.30) 1997 Modelled IHME
7.52 (5.43 - 10.30) 1996 Modelled IHME
7.45 (5.17 - 10.60) 1995 Modelled IHME
7.46 (5.01 - 10.60) 1994 Modelled IHME
7.45 (5.09 - 10.70) 1993 Modelled IHME
7.41 (4.95 - 10.90) 1992 Modelled IHME
7.54 (4.99 - 10.90) 1991 Modelled IHME
7.63 (5.08 - 11) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
169 (119 - 235) 2019 Modelled IHME
168 (122 - 229) 2018 Modelled IHME
166 (125 - 218) 2017 Modelled IHME
163 (127 - 207) 2016 Modelled IHME
164 (128 - 207) 2015 Modelled IHME
158 (123 - 202) 2014 Modelled IHME
170 (133 - 217) 2013 Modelled IHME
174 (137 - 221) 2012 Modelled IHME
171 (133 - 217) 2011 Modelled IHME
175 (135 - 225) 2010 Modelled IHME
173 (133 - 223) 2009 Modelled IHME
171 (132 - 222) 2008 Modelled IHME
167 (129 - 217) 2007 Modelled IHME
160 (123 - 207) 2006 Modelled IHME
153 (119 - 201) 2005 Modelled IHME
162 (123 - 213) 2004 Modelled IHME
168 (127 - 222) 2003 Modelled IHME
164 (124 - 217) 2002 Modelled IHME
169 (129 - 225) 2001 Modelled IHME
162 (122 - 214) 2000 Modelled IHME
161 (122 - 213) 1999 Modelled IHME
157 (119 - 209) 1998 Modelled IHME
153 (116 - 205) 1997 Modelled IHME
150 (108 - 205) 1996 Modelled IHME
148 (103 - 211) 1995 Modelled IHME
148 (99 - 210) 1994 Modelled IHME
148 (101 - 213) 1993 Modelled IHME
147 (98 - 215) 1992 Modelled IHME
149 (99 - 215) 1991 Modelled IHME
150 (100 - 217) 1990 Modelled IHME
184 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
28 (20 - 36) 2019 Modelled IHME
28 (20 - 36) 2018 Modelled IHME
28 (20 - 37) 2017 Modelled IHME
28 (20 - 36) 2016 Modelled IHME
28 (20 - 36) 2015 Modelled IHME
28 (20 - 36) 2014 Modelled IHME
27 (20 - 36) 2013 Modelled IHME
27 (19 - 36) 2012 Modelled IHME
27 (19 - 36) 2011 Modelled IHME
27 (19 - 36) 2010 Modelled IHME
27 (19 - 36) 2009 Modelled IHME
27 (19 - 35) 2008 Modelled IHME
26 (19 - 35) 2007 Modelled IHME
26 (18 - 34) 2006 Modelled IHME
26 (18 - 34) 2005 Modelled IHME
26 (18 - 34) 2004 Modelled IHME
25 (18 - 34) 2003 Modelled IHME
26 (18 - 34) 2002 Modelled IHME
26 (18 - 34) 2001 Modelled IHME
26 (18 - 34) 2000 Modelled IHME
26 (18 - 34) 1999 Modelled IHME
26 (18 - 34) 1998 Modelled IHME
26 (18 - 34) 1997 Modelled IHME
26 (18 - 34) 1996 Modelled IHME
26 (18 - 34) 1995 Modelled IHME
26 (18 - 34) 1994 Modelled IHME
26 (18 - 34) 1993 Modelled IHME
26 (18 - 34) 1992 Modelled IHME
26 (18 - 34) 1991 Modelled IHME
26 (19 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
85 (65 - 122) 2014 Survey/reported Slovenia National Institute of Public Health, 2014.
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
62 2016 Survey/reported EMCDDA, 2019

Number of persons treated for HCV

National
Download
Value Year Type Source
172 2017 Survey/reported ECDC, 2019
Technical notes
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.84 (%)
2019
(0.73 - 0.95(%))
IHME
HCV (RNA/cAg+)
1.22 (%)
2019
(0.99 - 1.51(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
147
2019
(103 - 209)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
169
2019
(119 - 235)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.06 (%)
2019, latest modelled
(0.04 - 0.08(%))
IHME

Prevalence PWID

HCV
30.50 (%)
2014, latest modelled
(26.40 - 34.50(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
85
2014
(65 - 122)
Slovenia National Institute of Public Health, 2014.
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources

Programs